Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53072

言語	英語
著者	Maruyama Dai Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan Tsukasaki Kunihiro Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan Uchida Toshiki Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan Maeda Yoshinobu Okayama University Hospital, Okayama, Japan View author publications Shibayama Hirohiko Osaka University Hospital, Osaka, Japan Nagai Hirokazu Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan Kurosawa Mitsutoshi Hokkaido Cancer Center, Sapporo, Japan Suehiro Yoko Kyushu Cancer Center, Fukuoka, Japan Hatake Kiyohiko The Cancer Institute Hospital, Tokyo, Japan Ando Kiyoshi Tokai University Hospital, Isehara, Japan Yoshida Isao Shikoku Cancer Center, Matsuyama, Japan Hidaka Michihiro Kumamoto Medical Center, Kumamoto, Japan Murayama Tohru Hyogo Cancer Center, Akashi, Japan Okitsu Yoko Tohoku University Hospital, Sendai, Japan Tsukamoto Norifumi Gunma University Hospital, Maebashi, Japan Taniwaki Masafumi University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan 鈴宮淳司 Tamura Kazuo Fukuoka University Hospital, Fukuoka, Japan Yamauchi Takahiro Fukui University Hospital, Fukui, Japan Ueda Ryuzo Aichi Medical University, Nagakute, Japan Tobinai Kensei Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
主題	Forodesine; Peripheral T cell lymphoma; Overall response rate; Progression-free survival; Purine nucleoside phosphorylase inhibitor
掲載誌名	ANNALS OF HEMATOLOGY
巻	98
号	1
開始ページ	131
終了ページ	142
ISSN	0939-5555
ISSN（Online）	1432-0584
発行日	2019-01
DOI	10.1007/s00277-018-3418-2
PubMed ID	29974231
出版者	SPRINGER
資料タイプ	学術雑誌論文
部局	医学部
備考	This work was supported by Mundipharma K.K., Tokyo, Japan.